PT491 – Dr. Sam Banister – Drug Development, The State of Biotech, and Exploring Non-Hallucinogenic Compounds

PT491 – Dr. Sam Banister – Drug Development, The State of Biotech, and Exploring Non-Hallucinogenic Compounds

In this episode, Christopher Koddermann interviews Dr. Sam Banister: co-founder and chief scientific officer of Psylo, an Australian biotech company developing next-generation psychedelics.

Banister discusses how he got involved in drug development, how Psylo came about, and the hallucinogenic and non-hallucinogenic 5-HT2A agonists Psylo is working on. He talks about the compromise between immediate need and ambition, and the ethical considerations and possibilities behind developing non-hallucinogenic compounds: What can we take from the psychedelic experience for people who aren't ideal candidates for one? Is the psychedelic experience truly necessary? And for what indications will these new Gen 3 compounds be most useful?

He discusses:

  • What we can infer about the volatility of biotech and the state of the psychedelic industry based on recent mergers and acquisitions
  • The long-term challenges of drug development and the scalability of treatment options
  • How the initial success of Spravato has played a role in allaying fears around new compounds
  • Head twitch response and concerns it's not as accurate of a metric as we've believed
  • Australia's decision to down-schedule psilocybin and MDMA, and the speed of implementation and licensing: How long will it be before people have easy access?
  • What he sees for the future and why we need to be careful with language around expectations

and more!

Click here to head to teh show notes page.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(778)

PT 660 - Josh Lipson & Roman Palitsky: Psychedelic Harms and the Post-Psychedelic Challenges Study

PT 660 - Josh Lipson & Roman Palitsky: Psychedelic Harms and the Post-Psychedelic Challenges Study

This is an important discussion about harms, and what we should be doing about them. Josh and Roman are working on a major study at Emory University to answer some of the basic and outstanding questio...

12 Aug 1h 12min

PT 659 - Megan Bowers & Mikayla Hellwich

PT 659 - Megan Bowers & Mikayla Hellwich

This is a special episode featuring two of our favorite organizations. DanceSafe and Shulgin Foundation. Listen to Joe Moore record with the heads of these orgs and learn about how you may be able to ...

5 Aug 1h 20min

PT 658 - Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Without Psychedelics

PT 658 - Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Without Psychedelics

My friend Mareesa joins us again on PT to discuss art, integration, psychedelic experiences without drugs, the heros journey and her smaller sphinxes that may start touring the country! Enjoy! Here ar...

31 Jul 1h 15min

PT 657 - Rachel Turetzky PhD & Douglas S. Wingate DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

PT 657 - Rachel Turetzky PhD & Douglas S. Wingate DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy

Kyle and Joe interview Rachel Turetzky & Douglas S. Wingate about their perspectives on the Wilson\Leary 8 Circuit Model of consciousness. They recently released a CE approved program on Psychedelic E...

23 Jul 1h 18min

PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

PT 656 - Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture

Denver mushroom decriminalization changed the national conversation around psilocybin access, personal use, and grassroots psychedelic reform. In this episode of Psychedelics Today, Joe Moore speaks w...

11 Mai 1h 43min

PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium

PT 655 - Martha Hammel and Tasia Poinsatte - Aspen Psychedelic Symposium

Aspen Psychedelic Symposium is the focus of this conversation with Martha Hammel of the Aspen Psychedelic Resource Center and Tasia Poinsatte of Healing Advocacy Fund. They join Joe Moore to discuss t...

8 Mai 54min

PT 654 - Erica Rex - Seeing What Is There

PT 654 - Erica Rex - Seeing What Is There

Seeing What Is There is at the center of this conversation with journalist and author Erica Rex, who joins Joe Moore to discuss her book Seeing What Is There: My Search for Sanity in the Psychedelic E...

23 Apr 1h 20min

PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy

PT 653 - Dr. Michael Alpert and Peter Alberding - ALS, Existential Distress, and Ketamine Therapy

ALS and ketamine therapy are at the center of this conversation with psychiatrist Dr. Michael Alpert and Peter Alberding, who was diagnosed with ALS in late 2023. Alpert is a Boston-area psychiatrist ...

16 Apr 1h 19min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
rss-nysgjerrige-norge
liberal-halvtime
rekommandert
jss
villmarksliv
dekodet-2
abels-tarn
sinnsyn
vett-og-vitenskap-med-gaute-einevoll
fjellsportpodden
rss-overskuddsliv
rss-rekommandert
rss-paradigmepodden
tomprat-med-gunnar-tjomlid
diagnose
rss-inn-til-kjernen-med-sunniva-rose
nordnorsk-historie